The path of least resistance

被引:0
|
作者
Annette Fenner
机构
关键词
D O I
10.1038/nrurol.2015.288
中图分类号
学科分类号
摘要
引用
收藏
页码:5 / 5
相关论文
共 50 条
  • [21] Underemployment: Following the path of least resistance
    Jensen, DG
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1998, 11 (06): : 68 - 69
  • [22] Following their path of least resistance in thinking
    Morgan, JJB
    JOURNAL OF EDUCATIONAL PSYCHOLOGY, 1944, 35 : 27 - 38
  • [23] The path of least resistance: aggressive or moderate treatment?
    Kouyos, Roger D.
    Metcalf, C. Jessica E.
    Birger, Ruthie
    Klein, Eili Y.
    zur Wiesch, Pia Abel
    Ankomah, Peter
    Arinaminpathy, Nimalan
    Bogich, Tiffany L.
    Bonhoeffer, Sebastian
    Brower, Charles
    Chi-Johnston, Geoffrey
    Cohen, Ted
    Day, Troy
    Greenhouse, Bryan
    Huijben, Silvie
    Metlay, Joshua
    Mideo, Nicole
    Pollitt, Laura C.
    Read, Andrew F.
    Smith, David L.
    Standley, Claire
    Wale, Nina
    Grenfell, Bryan
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2014, 281 (1794)
  • [24] Precision antimicrobial therapeutics: the path of least resistance?
    Spaulding, Caitlin N.
    Klein, Roger D.
    Schreiber, Henry L.
    Janetka, James W.
    Hultgren, Scott J.
    NPJ BIOFILMS AND MICROBIOMES, 2018, 4
  • [25] Artur Schnabel, music and the path of least resistance
    Schipperges, Thomas
    MUSIKTHEORIE, 2011, 26 (04): : 373 - 374
  • [26] When the path of least resistance is doing everything
    Adler, Elizabeth C.
    PALLIATIVE & SUPPORTIVE CARE, 2017, 15 (02) : 270 - 271
  • [27] Moving precisely? Or taking the path of least resistance?
    Sahrmann, SA
    PHYSICAL THERAPY, 1998, 78 (11): : 1208 - 1219
  • [28] Endocrine therapy: defining the path of least resistance
    Andrew Stone
    Elizabeth A Musgrove
    Breast Cancer Research, 16
  • [29] Endocrine therapy: defining the path of least resistance
    Stone, Andrew
    Musgrove, Elizabeth A.
    BREAST CANCER RESEARCH, 2014, 16 (03):
  • [30] Precision antimicrobial therapeutics: the path of least resistance?
    Caitlin N. Spaulding
    Roger D. Klein
    Henry L. Schreiber
    James W. Janetka
    Scott J. Hultgren
    npj Biofilms and Microbiomes, 4